Predictors of Lower Extremity Amputation and Reamputation Associated With the Diabetic Foot

2017 ◽  
Vol 56 (6) ◽  
pp. 1218-1222 ◽  
Author(s):  
Erdinc Acar ◽  
Burkay Kutluhan Kacıra
2017 ◽  
Vol 47 ◽  
pp. 1109-1116 ◽  
Author(s):  
Fırat OZAN ◽  
Kaan GÜRBÜZ ◽  
İlhami ÇELİK ◽  
Zehra BEŞTEPE DURSUN ◽  
Erdal UZUN

2017 ◽  
Vol 11 (1) ◽  
pp. 17-21 ◽  
Author(s):  
Dane K. Wukich ◽  
Katherine M. Raspovic ◽  
Natalie C. Suder

Background. The aim of this study was to identify the most-feared complications of diabetes mellitus (DM), comparing those with diabetic foot pathology with those without diabetic foot pathology. Methods. We determined the frequency of patients ranking major lower-extremity amputation (LEA) as their greatest fear in comparison to blindness, death, diabetic foot infection (DFI), or end-stage renal disease (ESRD) requiring dialysis. We further categorized the study group patients (N = 207) by their pathology such as diabetic foot ulcer (DFU), Charcot neuroarthropathy, foot infection, or acute neuropathic fractures and dislocations. The control group (N = 254) was comprised of patients with diabetes who presented with common non–diabetes-related foot pathology. Results. A total of 461 patients were enrolled in this study and included 254 patients without diabetic foot complications and 207 patients with diabetic foot problems. When comparing patients with and without diabetic disease, no significant differences were observed with regard to their fear of blindness, DFI, or ESRD requiring dialysis. Patients with diabetic foot disease (61 of 207, 31.9%) were 136% more likely (odds ratio [OR] = 2.36; 95% CI = 1.51-3.70; P = .002] to rank major LEA as their greatest fear when compared with diabetic patients without foot disease (42 of 254, 16.5%) and were 49% less likely (OR = 0.51; 95% CI = 0.34-0.79; P = .002) to rank death as their greatest fear compared with patients without diabetic foot disease. Conclusion. Patients with diabetic foot pathology fear major LEA more than death, foot infection, or ESRD. Variables that were associated with ranking LEA as the greatest fear were the presence of a diabetic-related foot complication, duration of DM ≥10 years, insulin use, and the presence of peripheral neuropathy. Levels of Evidence: Level II: Prospective, Case controlled study


2021 ◽  
Vol 10 (23) ◽  
pp. 5598
Author(s):  
Hye Jin Kim ◽  
Chun-Gon Park ◽  
Yong Seon Choi ◽  
Yong Suk Lee ◽  
Hyun-Jeong Kwak

Diabetic foot amputation is associated with high morbidity and mortality rates. To prevent cardiovascular complications along with vasculopathy in the course of diabetes mellitus, a high number of patients receive anticoagulant therapy. However, anticoagulants are contraindicated in neuraxial anesthesia limiting available anesthetic modalities. Therefore, in this retrospective study, we aimed to compare between general anesthesia and peripheral nerve block (PNB) with respect to postoperative complications following lower extremity amputation (LEA) in patients with coagulation abnormalities. In total, 320 adult patients who underwent LEA for diabetic foot were divided into two groups according to the anesthetic type (general anesthesia vs. PNB). The inverse probability of treatment weighting was performed to balance the baseline patient characteristics and surgical risk between the two groups. The adjusted analysis showed that compared with the general anesthesia group, the PNB group had lower risks of pneumonia (odds ratio: 0.091, 95% confidence interval [CI]: 0.010–0.850, p = 0.0355), acute kidney injury (odds ratio: 0.078, 95% CI: 0.007–0.871, p = 0.0382), and total major complications (odds ratio: 0.603, 95% CI: 0.400–0.910, p = 0.0161). Additionally, general anesthesia was associated with a higher amount of intraoperative crystalloid administration and a requirement for more frequent vasopressors. In conclusion, PNB appears to be protective against complications following LEA in diabetes patients with coagulopathy.


Diabetes Care ◽  
2011 ◽  
Vol 34 (8) ◽  
pp. 1695-1700 ◽  
Author(s):  
Benjamin A. Lipsky ◽  
John A. Weigelt ◽  
Xiaowu Sun ◽  
Richard S. Johannes ◽  
Karen G. Derby ◽  
...  

Diabetes Care ◽  
2009 ◽  
Vol 33 (1) ◽  
pp. 98-100 ◽  
Author(s):  
M.-W. Sohn ◽  
R. M. Stuck ◽  
M. Pinzur ◽  
T. A. Lee ◽  
E. Budiman-Mak

Sign in / Sign up

Export Citation Format

Share Document